US20150313953A1 - Antifungal mixture witih fungal organism pythium oligandrum - Google Patents
Antifungal mixture witih fungal organism pythium oligandrum Download PDFInfo
- Publication number
- US20150313953A1 US20150313953A1 US14/735,347 US201514735347A US2015313953A1 US 20150313953 A1 US20150313953 A1 US 20150313953A1 US 201514735347 A US201514735347 A US 201514735347A US 2015313953 A1 US2015313953 A1 US 2015313953A1
- Authority
- US
- United States
- Prior art keywords
- weight percent
- composition
- pythium oligandrum
- mixture
- fungal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
-
- A01N63/04—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Definitions
- the invention relates to an antifungal mixture with fungal organism Pythium oligandrum designed for fighting fungi including fungal diseases and bacteria.
- Fungi and fungal diseases are a problem of every society and especially fungal diseases of skin of both people and animals belong to frequently occurring diseases of people and animals. Such fungal diseases are even more serious because they are usually transmitted not only by a direct contact of the sick and the healthy but also through the objects, which were in contact with the source of infection.
- Such methods also include e.g. the application of the fungus Pythium oligandrum according to the document CZ 9883 U1 in the form of the biological preparation for fighting the origins of dermatophysis, which includes the said fungal organism in the form of oospora as the effective substance, when the total number of oospora is 2 ⁇ 10 5 in 1 g of the preparation as a maximum.
- this solution has a limited range of application and its effective substance is only bound on the inorganic carrier, which is silicon dioxide.
- Fungi from walls and fungi, yeast fungi and bacteria from various objects are removed by means of a series of different preparations, which are, however, never based on the application of the effective substance of the fungal organism Pythium oligandrum.
- the fungal organism Pythium oligandrum from the kingdom Chromista Stramenopila is a strong mycoparasite; it parasites over 20 families of causative agents of fungal diseases and represents the dividing line between fungi and protozoa because of its sexual as well as asexual reproduction.
- the fibres of Pythium oligandrum penetrate the cells of the parasite (fungi, yeast fungi, bacteria) and draw the substances required for its own nutrition from them. On the basis of nutrition and spatial competition, it squeezes out the pathogens from the spaces.
- the nature of the activity of this fungus is, therefore, parasiting on fungi with the simultaneous production of enzymes, which further increase the efficiency of the fungus.
- Pythium oligandrum attacks the opponent with direct parasitism.
- Pythium oligandrum disappears from that locality (both human and animal bodies do not represent a natural environment for it and it cannot adapt to such environment) and it gives way for the re-settlement of the so-called normal micro-flora or, unless it finds new nutrition (fungi), it is encapsulated into dormancy conditions and its life cycle is paused.
- Pythium oligandrum can be used independently or in combination with other carriers (components) than silicon dioxide, which is also used according to the aforesaid applied design.
- the number of the reproduction organs of the fungal organism Pythium oligandrum according to this technical solution is higher than 2 ⁇ 10 5 in 1 g of the mixture.
- the weight expression it means that the mixture consists of 0.001 to 25 weight portions of Pythia oligandrum as a minimum and 75 to 99.999 weights portions of inert components.
- Pythium oligandrum also suppresses symptoms of other diseases than dermatophysis, namely also microbiological settlement of proboscis, other inflammations of buccal caxity, psoriasis, haemorrhoids, varicose ulcers, bed sores, “diabetic feet”, atopic eczema, acne, cold sores, sore spots, nail fungi, falling hair, dandruff or old-age itchiness.
- this solution can be newly used for suppressing mycotic infections and putrefactive processes on paws, cloven hoofs, hoofs, hair, skin, eyes, shells, in mouth, scales, mucous membranes and auditory passages of animals or in the body of animals.
- this new solution enables to use the mixture for the treatment of human diseases of fungal, bacterial or other origin on skin, mucous membranes, in the hair part or in the body of humans. Further to that, this solution enables to use the mixtures for animals against the diseases of fungal, bacterial or other origin on paws, cloven hoofs, hoofs, hair, skin, eyes, shells, in mouth, scales, mucous membranes and auditory passages of animals or in the body of animals.
- Another application is also the violation of bio-films on heterogeneous materials used both in human and veterinary medicine (artificial valves, joint replacements, contact lenses, catheters etc.).
- the technical solution also enables to eliminate microflora virtually from all objects, which come into contact with humans and animals, e.g. from interiors of the means of transport, seat furniture, animal cages etc.
- oligandrin Various inert carriers are used for the new mixtures in different ratios, which do not damage the microscopic fungus Pythium oligandrum (creation of the fungal fibres and characteristic echinate oospore, zoospore and zoosporangia) and producing various enzymes, which are collectively called oligandrin.
- Pythium oligandrum is used in various concentrations for these new mixtures, when the number of the reproductive organs of the fungal organism Pythium oligandrum is higher than 2 ⁇ 10 5 in 1 g of the mixture.
- the new inert components are especially biological organic and/or inorganic solutions, such as oil bases, physiological solutions, aromatic solutions, ointments, suppositories, pastes, creams, toothpastes, mouthwashes etc. Further to that, it concerns suspensions, emulsions or solid (loose) compositions of individual components, e.g. dusting powders, powders etc. or suspensions, emulsions or solutions from such individual substances.
- weight expression as stated above, it means that the mixture includes 0.001 to 25 weight portions of Pythium oligandrum and 75 to 99.999 weight portions of inert components.
- the activity of Pythium oligandrum in the mixture only arises after soaking or wetting e.g. also by skin, which is always sweating etc.
- the antifungal mixture with fungal organism Pythium oligandrum can be used both in human and veterinary medicine, in the cosmetic industry and also in households for maintaining cleanness and for elimination of fungi from walls of building objects and for violation of bio-films on heterogeneous materials and for elimination of microflora on objects coming in contact with humans or animals.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The antifungal mixture is designed for fighting human diseases and animal diseases of fungal, bacterial or other origin and for violation of bio-films on heterogeneous materials used both in human and veterinary medicine and for elimination of microflora from various objects coming in contact with humans or animals. The antifungal mixture uses the active component of the fungal organism Pythium oligandrum in the mixture with inert components; the said antifungal mixture contains 0.001 to 25 weight portions of the fungal organism Pythium oligandrum and 75 to 99.999 weight portions of inert components. The activity of the fungal organism Pythium oligandrum in the mixture arises at the moment when this organism gets in touch with humidity.
Description
- The invention relates to an antifungal mixture with fungal organism Pythium oligandrum designed for fighting fungi including fungal diseases and bacteria.
- Fungi and fungal diseases are a problem of every society and especially fungal diseases of skin of both people and animals belong to frequently occurring diseases of people and animals. Such fungal diseases are even more serious because they are usually transmitted not only by a direct contact of the sick and the healthy but also through the objects, which were in contact with the source of infection.
- The treatment of such dermatological diseases is very difficult and lengthy and nowadays, the treatment methods are based especially on the application of system antimycotics, exceptionally also chemotherapy, which means that aggressive forms of treatment with chemical therapeutics are used against pathogenic microorganisms, which cause the diseases; however, they usually impact not only the targeted pathogen but also the tissues of the recipient of the therapeutics. Other aggressive forms of treatment with antibiotics and hormones have contraindication, too.
- The said conservative types of treatment are often completed with cosmetic preparations, which are, however, based on the application of chemistry again, even though there are also natural cosmetic preparations, the basic source of which are substances of both floral and animal origin, including some inorganic substances occurring in nature (salts etc.).
- Only recently, dermatological troubles have started to be approached differentially and in a complex way and sensitive natural methods have been used preferentially more and more. Such methods also include e.g. the application of the fungus Pythium oligandrum according to the document CZ 9883 U1 in the form of the biological preparation for fighting the origins of dermatophysis, which includes the said fungal organism in the form of oospora as the effective substance, when the total number of oospora is 2×105 in 1 g of the preparation as a maximum. However, this solution has a limited range of application and its effective substance is only bound on the inorganic carrier, which is silicon dioxide.
- Fungi from walls and fungi, yeast fungi and bacteria from various objects are removed by means of a series of different preparations, which are, however, never based on the application of the effective substance of the fungal organism Pythium oligandrum.
- The above mentioned disadvantages of the current solutions are eliminated to a certain extent with the antifungal mixture with the fungal organism Pythium oligandrum according to the invention, where the effective substance of the fungal organism is used in higher concentrations and with the application of new components of the final mixtures and newly also zoospore and zoosporangia and enzymes.
- The fungal organism Pythium oligandrum from the kingdom Chromista Stramenopila is a strong mycoparasite; it parasites over 20 families of causative agents of fungal diseases and represents the dividing line between fungi and protozoa because of its sexual as well as asexual reproduction. The fibres of Pythium oligandrum penetrate the cells of the parasite (fungi, yeast fungi, bacteria) and draw the substances required for its own nutrition from them. On the basis of nutrition and spatial competition, it squeezes out the pathogens from the spaces. The nature of the activity of this fungus is, therefore, parasiting on fungi with the simultaneous production of enzymes, which further increase the efficiency of the fungus. It can be said that Pythium oligandrum attacks the opponent with direct parasitism. After the achievement of the task, i.e. exhaustion of the parasite, Pythium oligandrum disappears from that locality (both human and animal bodies do not represent a natural environment for it and it cannot adapt to such environment) and it gives way for the re-settlement of the so-called normal micro-flora or, unless it finds new nutrition (fungi), it is encapsulated into dormancy conditions and its life cycle is paused.
- It has been newly detected that for suppressing fungal diseases and their symptoms, it is more advantageous to use higher concentrations of the effective substance, i.e. reproduction organs, than 2×105 in 1 g of the mixture. Further to that, Pythium oligandrum can be used independently or in combination with other carriers (components) than silicon dioxide, which is also used according to the aforesaid applied design.
- Higher concentrations of the effective substance can be achieved by the application of other reproduction organs of the fungal organism Pythium oligandrum than only oospore. The number of the reproduction organs of the fungal organism Pythium oligandrum according to this technical solution is higher than 2×105 in 1 g of the mixture. In terms of the weight expression, it means that the mixture consists of 0.001 to 25 weight portions of Pythia oligandrum as a minimum and 75 to 99.999 weights portions of inert components.
- A new finding also concerns other mechanisms of the effect. Many diseases are caused by the presence of bacteria. With its metabolism, Pythium oligandrum produces various enzymes used for the decomposition of host organisms. Such enzymes also represent unfavourable environment for bacteria and, at the same time, the presence of bacteria in the affected organs is supported by the occurrence of microscopic fungi producing nutrition components that are important to the bacterial development. Pythium oligandrum can parasite on such microscopic fungi and, thereby violate the environment suitable for the propagation of pathogenic bacteria. The combination of both factors results in the suppression of reproduction of bacteria, which cease in causing the putrefactive processes. In the same way, the bio-films are violated, which could cause diseases of the urinary system and, in case of occurrence on teeth, gingivitis or contaminate heterogeneous materials used in various treatment methods.
- Surprisingly it was detected that Pythium oligandrum also suppresses symptoms of other diseases than dermatophysis, namely also microbiological settlement of proboscis, other inflammations of buccal caxity, psoriasis, haemorrhoids, varicose ulcers, bed sores, “diabetic feet”, atopic eczema, acne, cold sores, sore spots, nail fungi, falling hair, dandruff or old-age itchiness. In the veterinary section, this solution can be newly used for suppressing mycotic infections and putrefactive processes on paws, cloven hoofs, hoofs, hair, skin, eyes, shells, in mouth, scales, mucous membranes and auditory passages of animals or in the body of animals.
- Therefore, this new solution enables to use the mixture for the treatment of human diseases of fungal, bacterial or other origin on skin, mucous membranes, in the hair part or in the body of humans. Further to that, this solution enables to use the mixtures for animals against the diseases of fungal, bacterial or other origin on paws, cloven hoofs, hoofs, hair, skin, eyes, shells, in mouth, scales, mucous membranes and auditory passages of animals or in the body of animals.
- Another application is also the violation of bio-films on heterogeneous materials used both in human and veterinary medicine (artificial valves, joint replacements, contact lenses, catheters etc.). The technical solution also enables to eliminate microflora virtually from all objects, which come into contact with humans and animals, e.g. from interiors of the means of transport, seat furniture, animal cages etc.
- The above mentioned new applications of the fungal organism Pythium oligandrum are also enabled by the new application of other components forming the mixture. New mixtures were examined and selected because of better, more understandable and more comfortable application of the preparation for the consumer so that their possible preparation for application and the actual application were clear, simple and comfortable and corresponded to the common habits in the twenty first century. At the same time, they shall also comply with the requirements for the purpose of application. Various inert carriers are used for the new mixtures in different ratios, which do not damage the microscopic fungus Pythium oligandrum (creation of the fungal fibres and characteristic echinate oospore, zoospore and zoosporangia) and producing various enzymes, which are collectively called oligandrin.
- Pythium oligandrum is used in various concentrations for these new mixtures, when the number of the reproductive organs of the fungal organism Pythium oligandrum is higher than 2×105 in 1 g of the mixture.
- The new inert components are especially biological organic and/or inorganic solutions, such as oil bases, physiological solutions, aromatic solutions, ointments, suppositories, pastes, creams, toothpastes, mouthwashes etc. Further to that, it concerns suspensions, emulsions or solid (loose) compositions of individual components, e.g. dusting powders, powders etc. or suspensions, emulsions or solutions from such individual substances. In terms of weight expression, as stated above, it means that the mixture includes 0.001 to 25 weight portions of Pythium oligandrum and 75 to 99.999 weight portions of inert components.
- The activity of Pythium oligandrum in the mixture only arises after soaking or wetting e.g. also by skin, which is always sweating etc.
-
-
Pythium oligandrum 10.1% Inert component 89.9% of which Citric acid 33.3% Sodium carbonate 2.6% Spearmint aroma 0.45% Sorbitol 23.45% Sodium acid carbonate 26.79% Polyethylene glycol 6000 3.34% -
-
Pythium oligandrum 0.5% Inert component 99.5% of which Residue of dried organic cultivation medium approx. 9.5% Refined olive oil 85.09% Colloid silicon dioxide (Aerosil 200) 4.8% Vitamin E (Covi ox T 70) 0.08% Eucalyptus oil 0.03% -
-
Pythium oligandrum 1.72% Inert component 98.28% of which Residue of dried organic cultivation medium approx. 30.5% Refined almond oil 61.37% Aerosol 200 6.30% Sea buckthorn oil 1.65% Vitamin E (Covi ox T 70) 0.08% Balm oil 0.03% -
-
Pythium oligandrum 0.25-0.5% Inert component 99.75-99.5% of which Residue of dried organic cultivation medium 4.75-9.5% approx. Shea butter BIO (BIO Butyrospermum Partii 34.5% Butter) Sunflower oil BIO (BIO Helianthus Annuus 34.5% Seed Oil) Beeswax (Cera Alba) 11% Silica sand (Oxidum silicii) 10-15% -
-
Pythium oligandrum 25.0% Inert component 75.0% of which Refined olive oil 27.5% Shea butter (Cetiol SB 45) 22.0% Fish oil with vitamin E 18.5% Glycerol monostearate (Cutina GMS V) 2.6% Sea buckthorn oil 3.3% Covi ox T 70 1.1% - The antifungal mixture with fungal organism Pythium oligandrum can be used both in human and veterinary medicine, in the cosmetic industry and also in households for maintaining cleanness and for elimination of fungi from walls of building objects and for violation of bio-films on heterogeneous materials and for elimination of microflora on objects coming in contact with humans or animals.
Claims (6)
1-2. (canceled)
3. A method for treating human or animal skin which is dry from damage of diabetes, comprising the steps of:
(a) providing a composition comprising a mixture of between 0.001 weight percent and 25 weight percent of Pythium oligandrum and between 99.999 weight percent and 75 weight percent of an inert carrier, said composition containing fungal fibres, echinate oospores, zoospores, zoosporangia and active enzymes, the composition containing a number of reproductive organs of Pythium oligandrum higher than 2×105 in a gram of the composition, and
(b) applying an effective amount of said composition on said human or animal skin which dry from damage of diabetes.
4-10. (canceled)
11. A method for treating fungal or bacterial microflora on clothing, accessories, bed linens, walls and materials, comprising the steps of:
a) providing a composition comprising a mixture of between 0.001 weight percent and 25 weight percent of Pythium oligandrum and between 99.999 weight percent and 75 weight percent of an inert carrier, said composition containing fungal fibres, echinate oospores zoospores, zoosporangia and active enzymes, the number of reproductive organs of Pythium oligandrum higher than 2×105 in a gram of the composition, and
(b) applying an effective amount of aid composition on said fungal or bacterial microflora.
12. A method for treating skin, nails, mucous surfaces and hairs of humans, comprising the steps of:
(a) providing a composition comprising a mixture of between 0.001 weight percent and 25 weight percent of Pythium oligandrum and between 99.999 weight percent and 75 weight percent of an inert carrier, said composition containing fungal fibres, echinate oospores, zoospores, zoosporangia and active enzymes, the composition containing a number of reproductive organs of Pythium oligandrum higher than 2×105 in a gram of the composition, and
(b) applying an effective amount of said composition on said skin, nails, mucous surfaces and hairs of humans.
13. A method for treating paws, cloven hoofs, hoofs, hair, skin, eyes, shells, mouth scales, mucous surfaces and auditory passages of animals, comprising the steps of:
(a) providing a composition comprising a mixture of between 0.001 weight percent and 25 weight percent of Pythium oligandrum and between 99.999 weight percent and 75 weight percent of an inert carrier, said composition containing fungal fibres, echinate oospores, zoospores, zoosporangia and active enzymes, the composition containing a number of reproductive organs of Pythium oligandrum higher than 2×105 in a gram of the composition, and
(b) applying an effective amount of said composition on said paws, cloven hoofs, hoofs, hair, skin, eyes, shells, mouth scales, mucous surfaces and auditory passages of animals.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/735,347 US20150313953A1 (en) | 2009-11-04 | 2015-06-10 | Antifungal mixture witih fungal organism pythium oligandrum |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ20090724A CZ302297B6 (en) | 2009-11-04 | 2009-11-04 | Mildew-proof mixture containing Pythium oligandrum fungal organism |
CZPV2009-724 | 2009-11-04 | ||
PCT/CZ2009/000154 WO2011054322A1 (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture with fungal organism pythium oligandrum |
US201213505788A | 2012-05-03 | 2012-05-03 | |
US14/152,554 US9084750B2 (en) | 2009-11-04 | 2014-01-10 | Antifungal mixture with fungal organism Pythium oligandrum |
US14/735,347 US20150313953A1 (en) | 2009-11-04 | 2015-06-10 | Antifungal mixture witih fungal organism pythium oligandrum |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/152,554 Continuation US9084750B2 (en) | 2009-11-04 | 2014-01-10 | Antifungal mixture with fungal organism Pythium oligandrum |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150313953A1 true US20150313953A1 (en) | 2015-11-05 |
Family
ID=42289467
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/505,788 Abandoned US20120225035A1 (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture with fungal organism pythium oligandrum |
US14/152,554 Active US9084750B2 (en) | 2009-11-04 | 2014-01-10 | Antifungal mixture with fungal organism Pythium oligandrum |
US14/735,347 Abandoned US20150313953A1 (en) | 2009-11-04 | 2015-06-10 | Antifungal mixture witih fungal organism pythium oligandrum |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/505,788 Abandoned US20120225035A1 (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture with fungal organism pythium oligandrum |
US14/152,554 Active US9084750B2 (en) | 2009-11-04 | 2014-01-10 | Antifungal mixture with fungal organism Pythium oligandrum |
Country Status (16)
Country | Link |
---|---|
US (3) | US20120225035A1 (en) |
EP (1) | EP2496088B1 (en) |
JP (2) | JP6053521B2 (en) |
CN (1) | CN102655754B (en) |
AU (1) | AU2009354904B2 (en) |
BR (1) | BR112012010689B8 (en) |
CA (1) | CA2779541C (en) |
CZ (1) | CZ302297B6 (en) |
EA (1) | EA033217B1 (en) |
IL (1) | IL219510A (en) |
MA (1) | MA33756B1 (en) |
MX (1) | MX337150B (en) |
TN (1) | TN2012000194A1 (en) |
UA (1) | UA107204C2 (en) |
WO (1) | WO2011054322A1 (en) |
ZA (1) | ZA201203481B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130034618A1 (en) * | 2011-08-04 | 2013-02-07 | Karen Swenholt | Compositions for treating the integument |
CZ201523A3 (en) * | 2015-01-16 | 2016-07-27 | Bio Agens Research And Development - Bard, S.R.O. | Dual microbial preparation for long-term suppression or prevention of symptoms of opportunist microbial infections |
EP3324986B1 (en) * | 2015-07-20 | 2021-11-24 | Quorum Innovations, LLC | Materials and methods for improving immune responses and the skin and/or mucosal barrier function |
CN105519584A (en) * | 2016-01-12 | 2016-04-27 | 郑州曹氏天正生物技术有限公司 | Freeze-dried powdered, dried and suspended fungicide and preparation method thereof |
JP2019510036A (en) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | A detergent composition comprising probiotic / prebiotic active ingredients |
CA3018865A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
KR20190064563A (en) * | 2016-07-01 | 2019-06-10 | 바이오 아겐스 리서치 앤드 디벨롭먼트-바드 에스.알.오. | A method for determining the cell viability of a microorganism, a microorganism, a pythium oligandrum, a viable microorganism, a viable microorganism, and a method for determining the cell viability of a microorganism, How to |
CZ307642B6 (en) * | 2016-07-08 | 2019-01-30 | Bio Agens Research And Development - Bard S.R.O. | A preparation containing the viable mycoparasitic microorganism Pythium oligandrum for the treatment of dermatophytoses and yeast infections on the skin and mucous membranes and a method of application of the preparation |
CN110072392A (en) * | 2016-10-14 | 2019-07-30 | 生物制品有限责任公司 | Liquid bio antifungal prod and preparation method containing pythium oligandrum microorganism |
AU2017365019A1 (en) | 2016-11-23 | 2019-07-11 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
EA201990201A1 (en) * | 2017-10-16 | 2019-08-30 | Биопрепараты, Спол. С Р.О. | LIQUID BIOLOGICAL ANTI-FUNGAL DRUG CONTAINING THE PYTHIUM OLIGANDRUM MICRO-ORGANISM AND METHOD FOR PRODUCING IT |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS213659B1 (en) * | 1978-07-05 | 1982-04-09 | Dasa Vesely | Means for protection the sugar beet against the scarlet fever on the base of cospor mykroparazita pythium oligandrum |
EP0967877A1 (en) * | 1996-01-16 | 2000-01-05 | Sybron Chemical Holdings Inc. | Cleaner and sanitizer formulation |
US5961971A (en) * | 1996-10-17 | 1999-10-05 | University Of Florida | Biocontrol of fungal soilborne pathogens by Pythium oligandrum |
WO1999053762A1 (en) * | 1998-04-17 | 1999-10-28 | Microbia, Inc. | A method for efficient and highly selective control of microorganisms |
CZ9883U1 (en) * | 1999-11-18 | 2000-04-14 | Dasa Doc Ing Drsc Vesely | A skin protection agent using the fungus Pythium oligandrum |
CZ20013072A3 (en) * | 2001-08-24 | 2003-04-16 | Dáša Doc. Ing. Drsc. Veselý | Pythium oligandrum, resistance inducer to leaf diseases |
WO2009132343A1 (en) * | 2008-04-25 | 2009-10-29 | Nanobio Corporation | Nanoemulsions for treating onchomycosis |
CZ20377U1 (en) * | 2009-11-04 | 2009-12-18 | Bio Agens Research And Development - Bard, S.R.O. | Mildew-proof mixture containing Pythium oligandrum fungal organism |
-
2009
- 2009-11-04 CZ CZ20090724A patent/CZ302297B6/en unknown
- 2009-12-14 UA UAA201206771A patent/UA107204C2/en unknown
- 2009-12-14 BR BR112012010689A patent/BR112012010689B8/en active IP Right Grant
- 2009-12-14 CN CN200980162343.5A patent/CN102655754B/en active Active
- 2009-12-14 EP EP09809019.4A patent/EP2496088B1/en active Active
- 2009-12-14 US US13/505,788 patent/US20120225035A1/en not_active Abandoned
- 2009-12-14 AU AU2009354904A patent/AU2009354904B2/en not_active Ceased
- 2009-12-14 EA EA201270615A patent/EA033217B1/en not_active IP Right Cessation
- 2009-12-14 MX MX2012005278A patent/MX337150B/en active IP Right Grant
- 2009-12-14 WO PCT/CZ2009/000154 patent/WO2011054322A1/en active Application Filing
- 2009-12-14 JP JP2012537295A patent/JP6053521B2/en active Active
- 2009-12-14 CA CA2779541A patent/CA2779541C/en active Active
-
2012
- 2012-04-26 TN TNP2012000194A patent/TN2012000194A1/en unknown
- 2012-05-01 IL IL219510A patent/IL219510A/en active IP Right Grant
- 2012-05-14 ZA ZA2012/03481A patent/ZA201203481B/en unknown
- 2012-05-17 MA MA34876A patent/MA33756B1/en unknown
-
2014
- 2014-01-10 US US14/152,554 patent/US9084750B2/en active Active
-
2015
- 2015-06-10 US US14/735,347 patent/US20150313953A1/en not_active Abandoned
-
2016
- 2016-08-29 JP JP2016166810A patent/JP2017019832A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20140127167A1 (en) | 2014-05-08 |
IL219510A (en) | 2017-01-31 |
AU2009354904A1 (en) | 2012-06-21 |
MX2012005278A (en) | 2012-08-23 |
CA2779541C (en) | 2018-12-04 |
CZ2009724A3 (en) | 2011-02-09 |
EP2496088A1 (en) | 2012-09-12 |
MA33756B1 (en) | 2012-11-01 |
JP6053521B2 (en) | 2016-12-27 |
IL219510A0 (en) | 2012-06-28 |
UA107204C2 (en) | 2014-12-10 |
US20120225035A1 (en) | 2012-09-06 |
CZ302297B6 (en) | 2011-02-09 |
CN102655754B (en) | 2017-08-22 |
CN102655754A (en) | 2012-09-05 |
BR112012010689B1 (en) | 2020-12-22 |
WO2011054322A1 (en) | 2011-05-12 |
TN2012000194A1 (en) | 2013-12-12 |
BR112012010689B8 (en) | 2021-05-25 |
EP2496088B1 (en) | 2018-12-05 |
EA033217B1 (en) | 2019-09-30 |
AU2009354904B2 (en) | 2014-12-04 |
BR112012010689A2 (en) | 2015-09-15 |
CA2779541A1 (en) | 2011-05-12 |
JP2013510100A (en) | 2013-03-21 |
EA201270615A1 (en) | 2012-09-28 |
WO2011054322A8 (en) | 2012-06-07 |
US9084750B2 (en) | 2015-07-21 |
JP2017019832A (en) | 2017-01-26 |
ZA201203481B (en) | 2012-12-27 |
MX337150B (en) | 2016-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9084750B2 (en) | Antifungal mixture with fungal organism Pythium oligandrum | |
EP2296614B1 (en) | Synergistic preservative blends | |
CN1736198A (en) | Deep penetrating anti-microbial compositions | |
CA2627430A1 (en) | Growth control of oral and superficial microorganisms using gallium compounds | |
CN106029062A (en) | Compositions and method for destabilizing, altering, and dispersing biofilms | |
US20190274948A1 (en) | Prebiotic cosmetic compositions and use of the prebiotic cosmetic compositions | |
Johari et al. | Inhibitory effects of silver zeolite on in vitro growth of fish egg pathogen, Saprolegnia sp | |
JP2016525068A (en) | Synergistic preservative blend | |
EP1883401B1 (en) | Anti-microbial agent | |
AU2012100972A4 (en) | Antifungal mixture with fungal organism pythium oligandrum | |
CZ20377U1 (en) | Mildew-proof mixture containing Pythium oligandrum fungal organism | |
US11285122B2 (en) | Volatile organic compound formulations having antimicrobial activity | |
JP2018528154A (en) | Preparations for the treatment of dermatomycosis and yeast infections of the skin and mucous membranes, including the viable fungal parasitic microorganism Picium origandrum, methods for determining cell viability of the microorganism Picium origandrum and methods for applying the preparation | |
CN112516068A (en) | Application of bacillus subtilis in antibacterial, deodorizing and cleaning products | |
AU2019351157A1 (en) | Volatile organic compound formulations having antimicrobial activity | |
JP4451115B2 (en) | How to control bee diseases | |
Murugesan et al. | Antibacterial activity of honey against selected pyogenic bacteria | |
US20220218637A1 (en) | Volatile Organic Compound Formulations Having Antimicrobial Activity | |
Phalalo et al. | An Enzymatic Based Formulation for Cleaning and Disinfection of Medical Devices | |
US20240148932A1 (en) | Wound dressing with preventive biofilm additive | |
KR20230147054A (en) | Use of short-chain fatty acids as anti-dandruff agents | |
US20060229368A1 (en) | Medical application of oxidized monoterpenes | |
US20180250223A1 (en) | Probiotic-Containing Animal Shampoo and Methods of Use | |
CS264623B1 (en) | Biocide agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |